MRI has a significant role in the diagnosis of multiple sclerosis. The newer and newer treatment options of the disease make it necessary to monitor the effectiveness of the therapy. Besides the clinical signs (clinical relapses and progression), the different MRI parameters can also reflect the disease activity. In our current article we summarize those MRI markers, which best predict the long-term disability, based on the international standards.
|Translated title of the contribution||The role of mri in measuring the effect1vity of disease modifying treatments I|
|Number of pages||4|
|Publication status||Published - Mar 30 2018|
ASJC Scopus subject areas
- Clinical Neurology